All Insiders Activity for Rigel Pharmaceuticals Inc. (RIGL)

$ 3.08   0.07 (+2.33%) Volume: 2.14m 4:00 PM EST Dec 4, 2020
After Hours:  $ 3.00   -0.08 (-2.60%) Volume: 14.9k 5:57 PM EST Dec 4, 2020
Name: Transaction:
Date Name: Shares Transaction Value
05/22/19 Dean Schorno,
EVP &Chief Financial Officer
3,274 Buy at $2.1292 per share. $6,971
05/22/19 Dean Schorno,
EVP &Chief Financial Officer
46,726 Buy at $2.131 per share. $99,573
10/12/18 Nelson Cabatuan,
Principal Accounting Officer
10,000 Sell at $3.12 per share. $31,200
09/17/18 Anne-Marie Duliege,
EVP & Chief Medical Officer
115,500 Sell at $3.50 per share. $404,250
09/17/18 Anne-Marie Duliege,
EVP & Chief Medical Officer
37,500 Option Exercise at $2.11 per share. $79,125
09/17/18 Anne-Marie Duliege,
EVP & Chief Medical Officer
37,500 Sell at $3.50 per share. $131,250
09/17/18 Anne-Marie Duliege,
EVP & Chief Medical Officer
115,500 Option Exercise at $2.54 per share. $293,370
09/11/18 Eldon C. Mayer,
EVP & Chief Commercial Officer
50,000 Buy at $3.2268 per share. $161,340
09/10/18 Eldon C. Mayer,
EVP & Chief Commercial Officer
50,000 Buy at $3.2842 per share. $164,210
09/04/18 Anne-Marie Duliege,
EVP & Chief Medical Officer
16,500 Sell at $3.5067 per share. $57,861
09/04/18 Anne-Marie Duliege,
EVP & Chief Medical Officer
16,500 Option Exercise at $2.54 per share. $41,910
08/23/18 Eldon C. Mayer,
EVP & Chief Commercial Officer
100,000 Buy at $2.8232 per share. $282,320
08/17/18 Raul R. Rodriguez,
Director, CEO, President
114,000 Buy at $2.6316 per share. $300,002
07/02/18 Anne-Marie Duliege,
EVP & Chief Medical Officer
5,000 Sell at $2.7864 per share. $13,932
04/20/18 Anne-Marie Duliege,
EVP & Chief Medical Officer
5,000 Sell at $4.11 per share. $20,550
  Page 1 of 4   Next Page
View Section 16 Filings (Forms 3,4,5) for RIGL Insider Summary For RIGL